 Connection
Edwin Asturias to Aged, 80 and over
This is a "connection" page, showing publications Edwin Asturias has written about Aged, 80 and over.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.129 |
|
|
|
-
Olson D, Lamb MM, Connery AK, Colbert AM, Calvimontes DM, Bauer D, Paniagua-Avila MA, Martínez MA, Arroyave P, Hernandez S, Colborn KL, Roell Y, Waggoner JJ, Natrajan MS, Anderson EJ, Bolaños GA, El Sahly HM, Munoz FM, Asturias EJ. Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes. Pediatr Infect Dis J. 2023 09 01; 42(9):739-744.
Score: 0.081
-
Koumans EHA, Khan D, Trejo I, Deng L, Devine O, Smith-Jeffcoat SE, Hamid S, Patton ME, Carter E, Aggarwal M, Pham H, Patel K, Whitaker M, Wiegand RE, Gregory CO, Ortega-Sanchez IR, Derado G, Iuliano AD, Reed C, Hall AJ, Taylor CA, Havers F, Anderson BJ, Asturias E, Bowman NM, Chai SJ, Chu HY, Como-Sabetti K, Ellingson KD, Felsen CB, Grijalva CG, Hill M, Kawasaki B, Lutrick K, Maldonado Y, Martin ET, Monto AS, Morrissey KG, Naleway AL, Nguyen HQ, Plano J, Rao S, Ryan PA, Sosin DM, Stockwell MS, Sutton M, Talbot HK, Witt LS. Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024. JAMA Intern Med. 2026 03 01; 186(3):321-330.
Score: 0.025
-
Hills SL, Sutter RA, Miller ER, Asturias EJ, Chen LH, Bell BP, McNeil MM, Rakickas J, Wharton M, Meyer S, Staples JE. Surveillance for adverse events following use of live attenuated chikungunya vaccine, United States, 2024, and the associated public health response in 2024 and 2025. Euro Surveill. 2025 Aug; 30(32).
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|